Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Free e-Mail Client Login
biotechdaily.com
Genomics/Proteomics
Features Subscription Partner Sites Journal Info
GenologicsTHERMO FISHER SCIENTIFICROCHE APPLIED SCIENCE

Normal Brain Electrical Activity Protects Nerves from Huntington's Disease Peptides

By BiotechDaily International staff writers
Posted on 02 Dec 2009


ADVERTISEMENT
WATERS CORPORATION
The normal level of brain electrical activity (normal synaptic activity) protects nerve cells from the affect of the toxic peptides that characterize Huntington's disease.

Huntington's disease is a neurodegenerative disorder caused by a mutation in the gene that encodes for the huntingtin (Htt) protein. The mutated gene adds from one to many dozens of extra glutamine molecules to Htt. Incomplete breakdown of the enlarged protein results in the buildup of toxic, misfolded peptides that destroy cells in the nervous system.

Working with a mouse model of Huntington's disease, investigators at the Burnham Institute for Medical Research (La Jolla, CA, USA) examined the part played by brain electrical activity on the interaction between nerve cells and toxic Htt peptides.

They reported in the November 15, 2009, online edition of the journal Nature Medicine that normal synaptic receptor activity made nerve cells more resistant to Htt peptides. In contrast, excessive extrasynaptic electrical activity contributed to increased nerve cell death.

Treatment of mice that had been transfected with Htt peptides with low doses of the drug memantine, which is used to treat Alzheimer's disease, was found to effectively protect the animals' nerve cells. This was due to the action of the drug in reducing excessive NMDA-type glutamate receptor activity (synaptic N-methyl-D-aspartate-type glutamate receptor activity), which prevented the expression of excessive extasynaptic activity. However, high-doses of memantine stimulated disease progression, as it also blocked lower level protective synaptic NMDA receptor activity.

"Chronic neurodegenerative diseases like Huntington's, Alzheimer's and Parkinson's are all related to protein misfolding," said senior author Dr. Stuart A. Lipton, professor of neurosciences at the Burnham Institute. "We show here, for the first time, that electrical activity controls protein folding, and if you have a drug that can adjust the electrical activity to the correct levels, you can protect against misfolding. Also, this verifies that appropriate electrical activity is protective, supporting the ‘use it or lose it theory’ of brain activity at the molecular level. For example, this finding may explain why epidemiologists have found that "using" your brain by performing crossword puzzles and other games can stave off cognitive decline in diseases like Alzheimer's."

Related Links:
Burnham Institute for Medical Research





Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?




Microscopy Illumination
Microscopy Illumination
Pipette Alternative
Pipette Alternative
Detection System
Detection System

More Products

Latest Genomics/Proteomics News

Latest Issue
View Digital Edition
Subscribe / Renew
LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured MedBiz Market Reports
Premium Report Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
Featured Whitepaper
TriLink BioTechnologies:
Improved PCR flexibility with Hot Start dNTPs

Download Whitepaper
Events
2010 European Molecular Biology Laboratory (EMBO) Meeting
04 Sep 2010
07 Sep 2010


9th International Society for the Study of Xenobiotics (ISSX) Meeting
04 Sep 2010
08 Sep 2010


EFMC-ISMC 2010 - 21st International Symposium on Medicinal Chemistry
05 Sep 2010
09 Sep 2010


More events
THERMO FISHER SCIENTIFIC'
BMG LABTECH
THERMO FISHER SCIENTIFIC
GLOBETECH PUBLISHING
WEALTEC BIOSCIENCE
GLOBETECH PUBLISHING
Reed Expositions France
  biotechdaily.com Copyright � 2000-2010 Globetech Media. All rights reserved.